Go to Medications | Go to Definition
Lab Results, International
Associated Problem ID | Associated Problem Name | Data Domain | Coding System | Coding System Version | Lab Primary Key | Clinical Category | Result Name | LOINC Code | LOINC Component | LOINC Property | LOINC Time | LOINC System | LOINC Scale | LOINC Method | LOINC Long Name | Common US Use | Common Intl Use | Also Consider | LOINC Status | External Comments | % Consensus Agreement | PCM Status | Release Change Comments | PCM Version First Released | PCM Version Last Updated |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1.007 | Diabetes Mellitus | Labs | LOINC | 267,00 | 1.008.102 | Administrative | Interpretations, Comments, Notes, etc. associated with any lab results in this map will require look up and manual inclusion due to the variety of ways these are represented in information systems. | NA | NA | NA | NA | NA | NA | NA | NA | X | NA | Interpretations, Comments, Notes, etc. associated this lab test may require manual inclusion due to variety of ways represented. | PCM Team Decision | Active | 102,00 | ||||
1.000.256 | Hematology | Hemoglobin | 718-7 | Hemoglobin | MCnc | Pt | Bld | Qn | Hemoglobin [Mass/volume] in Blood | X | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.257 | Hematology | Hemoglobin Calculated | 20509-6 | Hemoglobin | MCnc | Pt | Bld | Qn | Calculated | Hemoglobin [Mass/volume] in Blood by calculation | X | X | ACTIVE | 100% | Active | 102,00 | |||||||||
1.000.258 | Hematology | Deprecated Hemoglobin | 42243-6 | Hemoglobin | MCnc | Pt | Bld | Qn | HPLC | Deprecated Hemoglobin [Mass/volume] in Blood | DEPRECATED | 100% | Active | 102,00 | |||||||||||
1.000.259 | Hematology | Hemoglobin by Oximetry | 55782-7 | Hemoglobin | MCnc | Pt | Bld | Qn | Oximetry | Hemoglobin [Mass/volume] in Blood by Oximetry | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.260 | Hematology | Hemoglobin Arterial | 30313-1 | Hemoglobin | MCnc | Pt | BldA | Qn | Hemoglobin [Mass/volume] in Arterial blood | X | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.261 | Hematology | Hemoglobin Arterial by Oximetry | 14775-1 | Hemoglobin | MCnc | Pt | BldA | Qn | Oximetry | Hemoglobin [Mass/volume] in Arterial blood by Oximetry | X | X | ACTIVE | 100% | Active | 102,00 | |||||||||
1.000.262 | Hematology | Hemoglobin Capillary | 30352-9 | Hemoglobin | MCnc | Pt | BldC | Qn | Hemoglobin [Mass/volume] in Capillary blood | X | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.268 | Hematology | Hemoglobin Mixed Venous | 30351-1 | Hemoglobin | MCnc | Pt | BldMV | Qn | Hemoglobin [Mass/volume] in Mixed venous blood | X | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.269 | Hematology | Hemoglobin Mixed Venous by Oximetry | 76768-1 | Hemoglobin | MCnc | Pt | BldMV | Qn | Oximetry | Hemoglobin [Mass/volume] in Mixed venous blood by Oximetry | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.270 | Hematology | Hemoglobin Venous | 30350-3 | Hemoglobin | MCnc | Pt | BldV | Qn | Hemoglobin [Mass/volume] in Venous blood | X | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.271 | Hematology | Hemoglobin Venous by Oximetry | 76769-9 | Hemoglobin | MCnc | Pt | BldV | Qn | Oximetry | Hemoglobin [Mass/volume] in Venous blood by Oximetry | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.273 | Hematology | Hemoglobin | 59260-0 | Hemoglobin | SCnc | Pt | Bld | Qn | Hemoglobin [Moles/volume] in Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.274 | Hematology | Hemoglobin Arterial | 75928-2 | Hemoglobin | SCnc | Pt | BldA | Qn | Hemoglobin [Moles/volume] in Arterial blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.275 | Hematology | Hemoglobin Venous | 93846-4 | Hemoglobin | SCnc | Pt | BldV | Qn | Hemoglobin [Moles/volume] in Venous blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.179 | Kidney Function Tests | Creatinine | 2160-0 | Creatinine | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.181 | Kidney Function Tests | Creatinine | 14682-9 | Creatinine | SCnc | Pt | Ser/Plas | Qn | Creatinine [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.182 | Kidney Function Tests | Creatinine Serum Plasma or Blood | 77140-2 | Creatinine | SCnc | Pt | Ser/Plas/Bld | Qn | Creatinine [Moles/volume] in Serum, Plasma or Blood | ACTIVE | Use only for a specific International laboratory system. US use discouraged. | 100% | Active | 102,00 | |||||||||||
1.000.253 | Kidney Function Tests | Creatinine Blood | 38483-4 | Creatinine | MCnc | Pt | Bld | Qn | Creatinine [Mass/volume] in Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.254 | Kidney Function Tests | Creatinine Arterial | 21232-4 | Creatinine | MCnc | Pt | BldA | Qn | Creatinine [Mass/volume] in Arterial blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.255 | Kidney Function Tests | Creatinine Blood | 59826-8 | Creatinine | SCnc | Pt | Bld | Qn | Creatinine [Moles/volume] in Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.175 | Kidney Function Tests | Estimated Creatinine Clearance by Cockcroft-Gault | 35591-7 | Creatinine renal clearance.predicted | VRat | Pt | Ser/Plas | Qn | Cockcroft-Gault formula | Creatinine renal clearance predicted by Cockcroft-Gault formula | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.176 | Kidney Function Tests | Estimated Creatinine Clearance by Cockcroft-Gault BSA | 35592-5 | Creatinine renal clearance/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas | Qn | Cockcroft-Gault formula, BSA formula | Creatinine renal clearance/1.73 sq M.predicted by Cockcroft-Gault formula, BSA formula | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.178 | Kidney Function Tests | Estimated Creatinine Clearance females by Cockcroft-Gault BSA | 50380-5 | Creatinine renal clearance/1.73 sq M.predicted.female | ArVRat | Pt | Ser/Plas | Qn | Cockcroft-Gault formula, BSA formula | Creatinine renal clearance/1.73 sq M.predicted among females by Cockcroft-Gault formula, BSA formula | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.177 | Kidney Function Tests | Estimated Creatinine Clearance males by Cockcroft-Gault BSA | 50381-3 | Creatinine renal clearance/1.73 sq M.predicted.male | ArVRat | Pt | Ser/Plas | Qn | Cockcroft-Gault formula, BSA formula | Creatinine renal clearance/1.73 sq M.predicted among males by Cockcroft-Gault formula, BSA formula | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.250 | Kidney Function Tests | Creatinine Pre Contrast | 72271-0 | Creatinine^pre contrast | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma --pre contrast | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.251 | Kidney Function Tests | Creatinine Pre Dialysis | 11042-9 | Creatinine^pre dialysis | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma --pre dialysis | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.252 | Kidney Function Tests | Creatinine Pre Dialysis | 51619-5 | Creatinine^pre dialysis | SCnc | Pt | Ser/Plas | Qn | Creatinine [Moles/volume] in Serum or Plasma --pre dialysis | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.011 | Kidney Function Tests | Deprecated eGFR by Schwartz | 50383-9 | Glomerular filtration rate.predicted | VRat | Pt | Ser/Plas | Qn | Creatinine-based formula (Schwartz) | Deprecated Glomerular filtration rate/1.73 sq M.predicted in 24 hour by Creatinine-based formula (Schwartz) | DEPRECATED | 100% | Active | 102,00 | |||||||||||
1.000.000 | Kidney Function Tests | eGFR | 69405-9 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas/Bld | Qn | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.001 | Kidney Function Tests | eGFR by CKD-EPI | 62238-1 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (CKD-EPI) | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) | X | X | ACTIVE | 100% | Active | 102,00 | |||||||||
1.000.004 | Kidney Function Tests | eGFR Blood by MDRD (Discouraged) | 76633-7 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Bld | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted by Creatinine-based formula (MDRD) in Blood | DISCOURAGED | 100% | Active | 102,00 | |||||||||||
1.000.005 | Kidney Function Tests | eGFR by MDRD (Discouraged) | 33914-3 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) | DISCOURAGED | 100% | Active | 102,00 | |||||||||||
1.000.006 | Kidney Function Tests | eGFR by MDRD | 77147-7 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) | X | X | ACTIVE | 100% | Active | 102,00 | |||||||||
1.000.012 | Kidney Function Tests | eGFR by Schwartz | 50384-7 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (Schwartz) | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (Schwartz) | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.013 | Kidney Function Tests | eGFR by Cystatin | 50210-4 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas/Bld | Qn | Cystatin-based formula | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Cystatin-based formula | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.002 | Kidney Function Tests | eGFR by CKD-EPI in blacks | 88293-6 | Glomerular filtration rate/1.73 sq M.predicted.black | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (CKD-EPI) | Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.007 | Kidney Function Tests | eGFR by MDRD in blacks | 48643-1 | Glomerular filtration rate/1.73 sq M.predicted.black | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) | X | X | ACTIVE | 100% | Active | 102,00 | |||||||||
1.000.008 | Kidney Function Tests | eGFR by MDRD in females | 50044-7 | Glomerular filtration rate/1.73 sq M.predicted.female | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted among females [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.009 | Kidney Function Tests | eGFR by MDRD in males | 70969-1 | Glomerular filtration rate/1.73 sq M.predicted.male | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted among males [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.003 | Kidney Function Tests | eGFR by CKD-EPI in non-blacks | 88294-4 | Glomerular filtration rate/1.73 sq M.predicted.non black | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (CKD-EPI) | Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.010 | Kidney Function Tests | eGFR by MDRD in non-blacks | 48642-3 | Glomerular filtration rate/1.73 sq M.predicted.non black | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) | X | X | ACTIVE | 100% | Active | 102,00 | |||||||||
1.000.425 | Liver Function Tests | ALT (SGPT) | 1742-6 | Alanine aminotransferase | CCnc | Pt | Ser/Plas | Qn | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | X | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.426 | Liver Function Tests | ALT (SGPT) Without P5'P | 1744-2 | Alanine aminotransferase | CCnc | Pt | Ser/Plas | Qn | No addition of P-5'-P | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P | X | X | ACTIVE | 100% | Active | 102,00 | |||||||||
1.000.427 | Liver Function Tests | ALT (SGPT) by P5'P | 1743-4 | Alanine aminotransferase | CCnc | Pt | Ser/Plas | Qn | With P-5'-P | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.428 | Liver Function Tests | ALT (SGPT) Serum Plasma or Blood | 77144-4 | Alanine aminotransferase | CCnc | Pt | Ser/Plas/Bld | Qn | Alanine aminotransferase [Enzymatic activity/volume] in Serum, Plasma or Blood | ACTIVE | Use only for a specific International laboratory system. US use discouraged. | 100% | Active | 102,00 | |||||||||||
1.000.423 | Liver Function Tests | ALT (SGPT) Blood | 76625-3 | Alanine aminotransferase | CCnc | Pt | Bld | Qn | Alanine aminotransferase [Enzymatic activity/volume] in Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.003.724 | Liver Function Tests | AST (SGOT) | 1920-8 | Aspartate aminotransferase | CCnc | Pt | Ser/Plas | Qn | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | X | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.003.725 | Liver Function Tests | AST (SGOT) Without P5'P | 88112-8 | Aspartate aminotransferase | CCnc | Pt | Ser/Plas | Qn | No addition of P-5'-P | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.003.726 | Liver Function Tests | AST (SGOT) by P5'P | 30239-8 | Aspartate aminotransferase | CCnc | Pt | Ser/Plas | Qn | With P-5'-P | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.306 | Lipids | Deprecated Total Cholesterol | 2565-0 | Cholesterol | MCnc | Pt | Ser/Plas | Qn | Deprecated Cholesterol [Mass/volume] in Serum or Plasma | DEPRECATED | 100% | Active | 102,00 | ||||||||||||
1.000.307 | Lipids | Total Cholesterol | 2093-3 | Cholesterol | MCnc | Pt | Ser/Plas | Qn | Cholesterol [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.308 | Lipids | Total Cholesterol Ultracentrifuged | 48620-9 | Cholesterol | MCnc | Pt | Ser/Plas.ultracentrifugate | Qn | Cholesterol [Mass/volume] in Serum or Plasma ultracentrifugate | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.310 | Lipids | Total Cholesterol | 14647-2 | Cholesterol | SCnc | Pt | Ser/Plas | Qn | Cholesterol [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.311 | Lipids | Deprecated Total Cholesterol Blood | 50339-1 | Cholesterol | MCnc | Pt | Bld | Qn | Deprecated Cholesterol [Mass/volume] in blood | DEPRECATED | 100% | Active | 102,00 | ||||||||||||
1.000.327 | Lipids | Deprecated HDL Cholesterol | 2086-7 | Cholesterol.in HDL | MCnc | Pt | Ser/Plas | Qn | Deprecated Cholesterol.in HDL [Mass/volume] in Serum or Plasma | DEPRECATED | 100% | Active | 102,00 | ||||||||||||
1.000.328 | Lipids | HDL Cholesterol | 2085-9 | Cholesterol.in HDL | MCnc | Pt | Ser/Plas | Qn | Cholesterol in HDL [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.330 | Lipids | HDL Cholesterol Ultracentrifuged | 18263-4 | Cholesterol.in HDL | MCnc | Pt | Ser/Plas.ultracentrifugate | Qn | Cholesterol in HDL [Mass/volume] in Serum or Plasma ultracentrifugate | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.333 | Lipids | HDL Cholesterol | 14646-4 | Cholesterol.in HDL | SCnc | Pt | Ser/Plas | Qn | Cholesterol in HDL [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.314 | Lipids | Deprecated LDL Cholesterol | 2090-9 | Cholesterol.in LDL | MCnc | Pt | Ser/Plas | Qn | Deprecated Cholesterol.in LDL [Mass/volume] in Serum or Plasma | DEPRECATED | 100% | Active | 102,00 | ||||||||||||
1.000.315 | Lipids | LDL Cholesterol | 2089-1 | Cholesterol.in LDL | MCnc | Pt | Ser/Plas | Qn | Cholesterol in LDL [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.316 | Lipids | LDL Calculated | 13457-7 | Cholesterol.in LDL | MCnc | Pt | Ser/Plas | Qn | Calculated | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.317 | Lipids | LDL Cholesterol Direct Assay | 18262-6 | Cholesterol.in LDL | MCnc | Pt | Ser/Plas | Qn | Direct assay | Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.319 | Lipids | LDL Cholesterol by VAP | 55440-2 | Cholesterol.in LDL | MCnc | Pt | Ser/Plas | Qn | VAP | Cholesterol.in LDL (real) [Mass/volume] in Serum or Plasma by VAP | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.320 | Lipids | LDL Cholesterol Ultracentrifuged | 18261-8 | Cholesterol.in LDL | MCnc | Pt | Ser/Plas.ultracentrifugate | Qn | Cholesterol in LDL [Mass/volume] in Serum or Plasma ultracentrifugate | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.322 | Lipids | LDL Cholesterol | 22748-8 | Cholesterol.in LDL | SCnc | Pt | Ser/Plas | Qn | Cholesterol in LDL [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.323 | Lipids | LDL Calculated | 39469-2 | Cholesterol.in LDL | SCnc | Pt | Ser/Plas | Qn | Calculated | Cholesterol in LDL [Moles/volume] in Serum or Plasma by calculation | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.324 | Lipids | LDL Cholesterol Direct Assay | 69419-0 | Cholesterol.in LDL | SCnc | Pt | Ser/Plas | Qn | Direct assay | Cholesterol in LDL [Moles/volume] in Serum or Plasma by Direct assay | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.352 | Lipids | Non-HDL Cholesterol | 43396-1 | Cholesterol.non HDL | MCnc | Pt | Ser/Plas | Qn | Cholesterol non HDL [Mass/volume] in Serum or Plasma | X | ACTIVE | 67% | Active | 102,00 | |||||||||||
1.000.353 | Lipids | Non-HDL Cholesterol | 70204-3 | Cholesterol.non HDL | SCnc | Pt | Ser/Plas | Qn | Cholesterol non HDL [Moles/volume] in Serum or Plasma | X | ACTIVE | 67% | Active | 102,00 | |||||||||||
1.000.339 | Lipids | Triglycerides | 2571-8 | Triglyceride | MCnc | Pt | Ser/Plas | Qn | Triglyceride [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.340 | Lipids | Triglycerides Calculated | 12951-0 | Triglyceride | MCnc | Pt | Ser/Plas | Qn | Calculated | Triglyceride [Mass/volume] in Serum or Plasma by calculation | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.343 | Lipids | Triglycerides | 14927-8 | Triglyceride | SCnc | Pt | Ser/Plas | Qn | Triglyceride [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.349 | Lipids | Triglycerides Blood | 3043-7 | Triglyceride | MCnc | Pt | Bld | Qn | Triglyceride [Mass/volume] in Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.350 | Lipids | Triglycerides Blood | 70218-3 | Triglyceride | SCnc | Pt | Bld | Qn | Triglyceride [Moles/volume] in Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.344 | Lipids | Triglycerides 12 Hours Fasting | 1644-4 | Triglyceride^post 12H CFst | MCnc | Pt | Ser/Plas | Qn | Triglyceride [Mass/volume] in Serum or Plasma --12 hours fasting | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.345 | Lipids | Triglycerides 12 Hours Fasting | 30524-3 | Triglyceride^post 12H CFst | SCnc | Pt | Ser/Plas | Qn | Triglyceride [Moles/volume] in Serum or Plasma --12 hours fasting | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.346 | Lipids | Deprecated Triglycerides Fasting | 17081-1 | Triglyceride^post CFst | MCnc | Pt | Ser | Qn | Deprecated Triglyceride [Mass/volume] in Serum or Plasma --post CFst | DEPRECATED | 100% | Active | 102,00 | ||||||||||||
1.000.347 | Lipids | Triglycerides Fasting | 3048-6 | Triglyceride^post CFst | MCnc | Pt | Ser/Plas | Qn | Triglyceride [Mass/volume] in Serum or Plasma --fasting | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.348 | Lipids | Triglycerides Fasting | 47210-0 | Triglyceride^post CFst | SCnc | Pt | Ser/Plas | Qn | Triglyceride [Moles/volume] in Serum or Plasma --fasting | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.005.923 | Diabetes Tests | Deprecated C Peptide | 27376-3 | C peptide | MCnc | Pt | Ser/Plas | Qn | Deprecated C peptide [Mass/volume] in Serum or Plasma | DEPRECATED | 100% | Active | 102,00 | ||||||||||||
1.005.924 | Diabetes Tests | C Peptide | 1986-9 | C peptide | MCnc | Pt | Ser/Plas | Qn | C peptide [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.005.925 | Diabetes Tests | C Peptide | 14633-2 | C peptide | SCnc | Pt | Ser/Plas | Qn | C peptide [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.005.928 | Diabetes Tests | C Peptide 24 Hour Urine Rate | 27944-8 | C peptide | MRat | 24H | Urine | Qn | C peptide [Mass/time] in 24 hour Urine | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.005.929 | Diabetes Tests | C Peptide 24 Hour Urine | 25872-3 | C peptide | SCnc | 24H | Urine | Qn | C peptide [Moles/volume] in 24 hour Urine | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.005.930 | Diabetes Tests | C Peptide Random Urine | 34253-5 | C peptide | SCnc | Pt | Urine | Qn | C peptide [Moles/volume] in Urine | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.005.931 | Diabetes Tests | C Peptide 24 Hour Urine Rate | 25358-3 | C peptide | SRat | 24H | Urine | Qn | C peptide [Moles/time] in 24 hour Urine | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.005.919 | Diabetes Tests | Deprecated Fructosamine | 2294-7 | Fructosamine | CCnc | Pt | Ser | Qn | Deprecated Fructosamine | DEPRECATED | 100% | Active | 102,00 | ||||||||||||
1.005.920 | Diabetes Tests | Fructosamine | 33805-3 | Fructosamine | MCnc | Pt | Ser/Plas | Qn | Fructosamine [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.005.921 | Diabetes Tests | Fructosamine | 15069-8 | Fructosamine | SCnc | Pt | Ser/Plas | Qn | Fructosamine [Moles/volume] in Serum or Plasma | X | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.000.460 | Diabetes Tests | Fasting Glucose Capillary | 1556-0 | Glucose^post CFst | MCnc | Pt | BldC | Qn | Fasting glucose [Mass/volume] in Capillary blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.462 | Diabetes Tests | Fasting Glucose Venous | 1557-8 | Glucose^post CFst | MCnc | Pt | BldV | Qn | Fasting glucose [Mass/volume] in Venous blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.463 | Diabetes Tests | Fasting Glucose Blood | 76629-5 | Glucose^post CFst | SCnc | Pt | Bld | Qn | Fasting glucose [Moles/volume] in Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.939 | Diabetes Tests | Fasting Glucose | 1558-6 | Glucose^post CFst | MCnc | Pt | Ser/Plas | Qn | Fasting glucose [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.940 | Diabetes Tests | Fasting Glucose | 14771-0 | Glucose^post CFst | SCnc | Pt | Ser/Plas | Qn | Fasting glucose [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.941 | Diabetes Tests | Fasting Glucose Serum, Plasma or Blood | 77145-1 | Glucose^post CFst | SCnc | Pt | Ser/Plas/Bld | Qn | Fasting glucose [Moles/volume] in Serum, Plasma or Blood | ACTIVE | Use only for a specific International laboratory system. US use discouraged. | 100% | Active | 102,00 | |||||||||||
1.002.907 | Diabetes Tests | HgbA1c | 41995-2 | Hemoglobin A1c | MCnc | Pt | Bld | Qn | Hemoglobin A1c [Mass/volume] in Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.002.908 | Diabetes Tests | HgbA1c | 4548-4 | Hemoglobin A1c/Hemoglobin.total | MFr | Pt | Bld | Qn | Hemoglobin A1c/Hemoglobin.total in Blood | X | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.002.909 | Diabetes Tests | HgbA1c Calculated | 17855-8 | Hemoglobin A1c/Hemoglobin.total | MFr | Pt | Bld | Qn | Calculated | Hemoglobin A1c/Hemoglobin.total in Blood by calculation | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.002.910 | Diabetes Tests | HgbA1c by Electrophoresis | 4549-2 | Hemoglobin A1c/Hemoglobin.total | MFr | Pt | Bld | Qn | Electrophoresis | Hemoglobin A1c/Hemoglobin.total in Blood by Electrophoresis | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.002.911 | Diabetes Tests | HgbA1c by HPLC | 17856-6 | Hemoglobin A1c/Hemoglobin.total | MFr | Pt | Bld | Qn | HPLC | Hemoglobin A1c/Hemoglobin.total in Blood by HPLC | X | X | ACTIVE | 100% | Active | 102,00 | |||||||||
1.002.912 | Diabetes Tests | HgbA1c by JDS/JSCC Protocol | 62388-4 | Hemoglobin A1c/Hemoglobin.total | MFr | Pt | Bld | Qn | JDS/JSCC | Hemoglobin A1c/Hemoglobin.total in Blood by JDS/JSCC protocol | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.002.913 | Diabetes Tests | HgbA1c | 71875-9 | Hemoglobin A1c/Hemoglobin.total | MFr.DF | Pt | Bld | Qn | Hemoglobin A1c/Hemoglobin.total [Pure mass fraction] in Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.002.914 | Diabetes Tests | HgbA1c by IFCC Protocol | 59261-8 | Hemoglobin A1c/Hemoglobin.total | SFr | Pt | Bld | Qn | IFCC | Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.003.325 | Endocrine Tests | Thyrotropin (TSH) Blood | 3015-5 | Thyrotropin | ACnc | Pt | Bld | Qn | Thyrotropin [Units/volume] in Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.003.327 | Endocrine Tests | Thyrotropin (TSH) | 3016-3 | Thyrotropin | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma | X | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.003.328 | Endocrine Tests | Thyrotropin (TSH) | 11580-8 | Thyrotropin | ACnc | Pt | Ser/Plas | Qn | Detection limit <= 0.005 mIU/L | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.005 mIU/L | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.003.329 | Endocrine Tests | Thyrotropin (TSH) | 11579-0 | Thyrotropin | ACnc | Pt | Ser/Plas | Qn | Detection limit <= 0.05 mIU/L | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L | X | X | ACTIVE | 100% | Active | 102,00 | |||||||||
1.003.330 | Endocrine Tests | Thyrotropin (TSH) (Discouraged) | 27975-2 | Thyrotropin | MCnc | Pt | Ser/Plas | Qn | Thyrotropin [Mass/volume] in Serum or Plasma | DISCOURAGED | 100% | Active | 102,00 | ||||||||||||
1.003.331 | Endocrine Tests | Thyrotropin (TSH) (Discouraged) | 14297-6 | Thyrotropin | SCnc | Pt | Ser/Plas | Qn | Thyrotropin [Moles/volume] in Serum or Plasma | DISCOURAGED | 100% | Active | 102,00 | ||||||||||||
1.003.348 | Endocrine Tests | Thyrotropin (TSH) 15 Mins Pre Dose Luteinizing Releasing Hormone IV | 47949-3 | Thyrotropin^15M pre dose lutenizing releasing hormone IV | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --15 minutes pre dose lutenizing releasing hormone IV | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.003.347 | Endocrine Tests | Thyrotropin (TSH) 15 Mins Pre Dose TRH IV | 44936-3 | Thyrotropin^15M pre dose TRH IV | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --15 minutes pre dose TRH IV | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.003.397 | Endocrine Tests | Thyrotropin (TSH) Baseline | 14999-7 | Thyrotropin^baseline | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --baseline | X | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.003.398 | Endocrine Tests | Thyrotropin (TSH) Baseline (Discouraged) | 1642-8 | Thyrotropin^baseline | MCnc | Pt | Ser/Plas | Qn | Thyrotropin [Mass/volume] in Serum or Plasma --baseline | DISCOURAGED | 100% | Active | 102,00 | ||||||||||||
1.003.406 | Endocrine Tests | Thyrotropin (TSH) Pre Dose Luteinizing Releasing Hormone IV | 47953-5 | Thyrotropin^pre dose lutenizing releasing hormone IV | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --pre dose lutenizing releasing hormone IV | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.003.401 | Endocrine Tests | Thyrotropin (TSH) Pre Dose TRH | 33269-2 | Thyrotropin^pre dose TRH | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --pre dose TRH | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.003.402 | Endocrine Tests | Thyrotropin (TSH) Pre Dose TRH IN (Discouraged) | 25991-1 | Thyrotropin^pre dose TRH IN | SCnc | Pt | Ser/Plas | Qn | Thyrotropin [Moles/volume] in Serum or Plasma --pre dose TRH IN | DISCOURAGED | 100% | Active | 102,00 | ||||||||||||
1.003.403 | Endocrine Tests | Deprecated Thyrotropin (TSH) Pre Dose TRH IN | 44937-1 | Thyrotropin^pre dose TRH IV | ACnc | Pt | Ser/Plas | Qn | Deprecated Thyrotropin [Units/volume] in Serum or Plasma --pre dose TRH IV | DEPRECATED | 100% | Active | 102,00 | ||||||||||||
1.003.404 | Endocrine Tests | Thyrotropin (TSH) Pre Dose TRH IV | 15000-3 | Thyrotropin^pre dose TRH IV | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --pre dose TRH IV | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.003.405 | Endocrine Tests | Thyrotropin (TSH) Pre Dose TRH IV (Discouraged) | 1643-6 | Thyrotropin^pre dose TRH IV | MCnc | Pt | Ser/Plas | Qn | Thyrotropin [Mass/volume] in Serum or Plasma --pre dose TRH IV | DISCOURAGED | 100% | Active | 102,00 | ||||||||||||
1.003.407 | Endocrine Tests | Thyrotropin (TSH) Pre Dose Triple Bolus | 40401-2 | Thyrotropin^pre dose triple bolus | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --pre dose triple bolus | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.430 | Other Blood Chemistry Tests | Deprecated Glucose | 6777-7 | Glucose | MCnc | Pt | Ser/Plas | Qn | Deprecated Glucose [Mass/volume] in Serum or Plasma | DEPRECATED | 83% | Active | 102,00 | ||||||||||||
1.000.431 | Other Blood Chemistry Tests | Glucose | 2345-7 | Glucose | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.432 | Other Blood Chemistry Tests | Glucose Serum, Plasma or Blood | 74774-1 | Glucose | MCnc | Pt | Ser/Plas/Bld | Qn | Glucose [Mass/volume] in Serum, Plasma or Blood | ACTIVE | Use only for a specific International laboratory system. US use discouraged. | 83% | Active | 102,00 | |||||||||||
1.000.434 | Other Blood Chemistry Tests | Glucose | 14749-6 | Glucose | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.435 | Other Blood Chemistry Tests | Glucose Serum, Plasma or Blood | 77135-2 | Glucose | SCnc | Pt | Ser/Plas/Bld | Qn | Glucose [Moles/volume] in Serum, Plasma or Blood | ACTIVE | Use only for a specific International laboratory system. US use discouraged. | 83% | Active | 102,00 | |||||||||||
1.000.440 | Other Blood Chemistry Tests | Glucose Blood | 2339-0 | Glucose | MCnc | Pt | Bld | Qn | Glucose [Mass/volume] in Blood | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.443 | Other Blood Chemistry Tests | Glucose Arterial | 41651-1 | Glucose | MCnc | Pt | BldA | Qn | Glucose [Mass/volume] in Arterial blood | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.444 | Other Blood Chemistry Tests | Glucose Capillary | 32016-8 | Glucose | MCnc | Pt | BldC | Qn | Glucose [Mass/volume] in Capillary blood | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.446 | Other Blood Chemistry Tests | Glucose Venous | 41652-9 | Glucose | MCnc | Pt | BldV | Qn | Glucose [Mass/volume] in Venous blood | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.448 | Other Blood Chemistry Tests | Glucose Blood | 15074-8 | Glucose | SCnc | Pt | Bld | Qn | Glucose [Moles/volume] in Blood | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.450 | Other Blood Chemistry Tests | Glucose Arterial | 39481-7 | Glucose | SCnc | Pt | BldA | Qn | Glucose [Moles/volume] in Arterial blood | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.451 | Other Blood Chemistry Tests | Glucose Capillary | 51596-5 | Glucose | SCnc | Pt | BldC | Qn | Glucose [Moles/volume] in Capillary blood | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.454 | Other Blood Chemistry Tests | Glucose Venous | 39480-9 | Glucose | SCnc | Pt | BldV | Qn | Glucose [Moles/volume] in Venous blood | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.625 | Other Blood Chemistry Tests | Glucose 1st Specimen | 50206-2 | Glucose^1st specimen | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --1st specimen | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.716 | Other Blood Chemistry Tests | Gluc 2nd Specimen | 50212-0 | Glucose^2nd specimen | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --2nd specimen | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.791 | Other Blood Chemistry Tests | Gluc 3rd Specimen | 50213-8 | Glucose^3rd specimen | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --3rd specimen | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.840 | Other Blood Chemistry Tests | Gluc 4th Specimen | 50214-6 | Glucose^4th specimen | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --4th specimen | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.011.075 | Other Blood Chemistry Tests | Glucose Comment or Interpretation | NA | NA | NA | NA | NA | NA | NA | NA | X | NA | Interpretations, Comments, Notes, etc. associated this lab test may require manual inclusion due to variety of ways represented. | PCM Team Decision | Active | 102,00 | |||||||||
1.003.017 | Urine Chemistry Tests | 24 Hour Urine Microalbumin | 53530-2 | Albumin | MCnc | 24H | Urine | Qn | Detection limit <= 1.0 mg/L | Microalbumin [Mass/volume] in 24 hour Urine by Detection limit <= 1.0 mg/L | X | ACTIVE | 83% | Active | 102,00 | ||||||||||
1.003.018 | Urine Chemistry Tests | 24 Hour Urine Microalbumin | 30003-8 | Albumin | MCnc | 24H | Urine | Qn | Detection limit <= 20 mg/L | Microalbumin [Mass/volume] in 24 hour Urine | X | ACTIVE | 83% | Active | 102,00 | ||||||||||
1.003.019 | Urine Chemistry Tests | 4 Hour Urine Microalbumin | 43605-5 | Albumin | MCnc | 4H | Urine | Qn | Detection limit <= 20 mg/L | Microalbumin [Mass/volume] in 4 hour Urine | X | ACTIVE | 83% | Active | 102,00 | ||||||||||
1.003.020 | Urine Chemistry Tests | Urine Microalbumin | 53531-0 | Albumin | MCnc | Pt | Urine | Qn | Detection limit <= 1.0 mg/L | Microalbumin [Mass/volume] in Urine by Detection limit <= 1.0 mg/L | X | ACTIVE | 83% | Active | 102,00 | ||||||||||
1.003.021 | Urine Chemistry Tests | Urine Microalbumin | 14957-5 | Albumin | MCnc | Pt | Urine | Qn | Detection limit <= 20 mg/L | Microalbumin [Mass/volume] in Urine | X | X | ACTIVE | 83% | Active | 102,00 | |||||||||
1.003.023 | Urine Chemistry Tests | Urine Albumin | 89999-7 | Albumin | MCnc | Pt | Urine | Qn | Detection limit <= 3.0 mg/L | Albumin [Mass/volume] in Urine by Detection limit <= 3.0 mg/L | X | ACTIVE | 83% | Active | 102,00 | ||||||||||
1.003.024 | Urine Chemistry Tests | 12 Hour Urine Microalbumin Rate | 43607-1 | Albumin | MRat | 12H | Urine | Qn | Detection limit <= 20 mg/L | Microalbumin [Mass/time] in 12 hour Urine | X | ACTIVE | 83% | Active | 102,00 | ||||||||||
1.003.025 | Urine Chemistry Tests | 18 Hour Urine Microalbumin Rate | 63474-1 | Albumin | MRat | 18H | Urine | Qn | Detection limit <= 20 mg/L | Microalbumin [Mass/time] in 18 hour Urine | X | ACTIVE | 83% | Active | 102,00 | ||||||||||
1.003.026 | Urine Chemistry Tests | 24 Hour Urine Microalbumin Rate | 53532-8 | Albumin | MRat | 24H | Urine | Qn | Detection limit <= 1.0 mg/L | Microalbumin [Mass/time] in 24 hour Urine by Detection limit <= 1.0 mg/L | X | ACTIVE | 83% | Active | 102,00 | ||||||||||
1.003.027 | Urine Chemistry Tests | 24 Hour Urine Microalbumin Rate | 14956-7 | Albumin | MRat | 24H | Urine | Qn | Detection limit <= 20 mg/L | Microalbumin [Mass/time] in 24 hour Urine | X | X | ACTIVE | 83% | Active | 102,00 | |||||||||
1.003.028 | Urine Chemistry Tests | 24 Hour Urine Albumin Rate | 90000-1 | Albumin | MRat | 24H | Urine | Qn | Detection limit <= 3.0 mg/L | Albumin [Mass/time] in 24 hour Urine by Detection limit <= 3.0 mg/L | X | ACTIVE | 83% | Active | 102,00 | ||||||||||
1.003.029 | Urine Chemistry Tests | 4 Hour Urine Microalbumin Rate | 43606-3 | Albumin | MRat | 4H | Urine | Qn | Detection limit <= 20 mg/L | Microalbumin [Mass/time] in 4 hour Urine | X | ACTIVE | 83% | Active | 102,00 | ||||||||||
1.003.030 | Urine Chemistry Tests | 8 Hour Urine Microalbumin Rate | 56553-1 | Albumin | MRat | 8H | Urine | Qn | Detection limit <= 20 mg/L | Microalbumin [Mass/time] in 8 hour Urine | X | ACTIVE | 83% | Active | 102,00 | ||||||||||
1.003.031 | Urine Chemistry Tests | Urine Microalbumin Rate Unspecified Duration | 49023-5 | Albumin | MRat | XXX | Urine | Qn | Detection limit <= 20 mg/L | Microalbumin [Mass/time] in Urine collected for unspecified duration | X | ACTIVE | 83% | Active | 102,00 | ||||||||||
1.003.032 | Urine Chemistry Tests | Urine Albumin | 77158-4 | Albumin | SCnc | Pt | Urine | Qn | Detection limit <= 3.0 mg/L | Albumin [Moles/volume] in Urine by Detection limit <= 3.0 mg/L | X | ACTIVE | 83% | Active | 102,00 | ||||||||||
1.003.016 | Urine Chemistry Tests | 12 Hour Urine Microalbumin | 57369-1 | Albumin | MCnc | 12H | Urine | Qn | Detection limit <= 20 mg/L | Microalbumin [Mass/volume] in 12 hour Urine | X | ACTIVE | 83% | Active | 102,00 | ||||||||||
1.003.033 | Urine Chemistry Tests | 24 Hour Urine Microalbumin Rate | 58448-2 | Albumin ug/min | MRat | 24H | Urine | Qn | Detection limit <= 20 mg/L | Microalbumin ug/min [Mass/time] in 24 hour Urine | X | X | ACTIVE | 83% | Active | 102,00 | |||||||||
1.003.034 | Urine Chemistry Tests | 12 Hour Urine Microalbumin / Creatinine Ratio | 44292-1 | Albumin/Creatinine | MRto | 12H | Urine | Qn | Detection limit <= 20 mg/L | Microalbumin/Creatinine [Mass Ratio] in 12 hour Urine | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.003.035 | Urine Chemistry Tests | 24 Hour Urine Microalbumin / Creatinine Ratio | 14958-3 | Albumin/Creatinine | MRto | 24H | Urine | Qn | Detection limit <= 20 mg/L | Microalbumin/Creatinine [Mass Ratio] in 24 hour Urine | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.003.036 | Urine Chemistry Tests | Urine Microalbumin / Creatinine Ratio | 14959-1 | Albumin/Creatinine | MRto | Pt | Urine | Qn | Detection limit <= 20 mg/L | Microalbumin/Creatinine [Mass Ratio] in Urine | X | X | ACTIVE | 100% | Active | 102,00 | |||||||||
1.003.037 | Urine Chemistry Tests | 24 Hour Urine Microalbumin / Creatinine Ratio | 77254-1 | Albumin/Creatinine | Ratio | 24H | Urine | Qn | Detection limit <= 1.0 mg/L | Microalbumin/Creatinine [Ratio] in 24 hour Urine by Detection limit <= 1.0 mg/L | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.003.038 | Urine Chemistry Tests | 24 Hour Urine Microalbumin / Creatinine Ratio | 59159-4 | Albumin/Creatinine | Ratio | 24H | Urine | Qn | Detection limit <= 20 mg/L | Microalbumin/Creatinine [Ratio] in 24 hour Urine | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.003.039 | Urine Chemistry Tests | Urine Microalbumin / Creatinine Ratio | 77253-3 | Albumin/Creatinine | Ratio | Pt | Urine | Qn | Detection limit <= 1.0 mg/L | Microalbumin/Creatinine [Ratio] in Urine by Detection limit <= 1.0 mg/L | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.003.040 | Urine Chemistry Tests | Urine Microalbumin / Creatinine Ratio | 30000-4 | Albumin/Creatinine | Ratio | Pt | Urine | Qn | Detection limit <= 20 mg/L | Microalbumin/Creatinine [Ratio] in Urine | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.003.042 | Urine Chemistry Tests | Urine Albumin / Creatinine Ratio | 89998-9 | Albumin/Creatinine | Ratio | Pt | Urine | Qn | Detection limit <= 3.0 mg/L | Albumin/Creatinine [Ratio] in Urine by Detection limit <= 3.0 mg/L | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
1.005.926 | Urine Chemistry Tests | C Peptide 24 Hour Urine | 55920-3 | C peptide | MCnc | 24H | Urine | Qn | C peptide [Mass/volume] in 24 hour Urine | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.005.927 | Urine Chemistry Tests | C Peptide Random Urine | 1987-7 | C peptide | MCnc | Pt | Urine | Qn | C peptide [Mass/volume] in Urine | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.005.942 | Challenge Tests | C Peptide 10 Mins Pre Challenge | 57645-4 | C peptide^10M pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | C peptide [Moles/volume] in Serum or Plasma --10 minutes pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.005.958 | Challenge Tests | C Peptide 15 Mins Pre Challenge | 58501-8 | C peptide^15M pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | C peptide [Mass/volume] in Serum or Plasma --15 minutes pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.005.959 | Challenge Tests | C Peptide 15 Mins Pre Challenge | 58502-6 | C peptide^15M pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | C peptide [Moles/volume] in Serum or Plasma --15 minutes pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.005.966 | Challenge Tests | C Peptide 1 Hour Pre Challenge | 57649-6 | C peptide^1H pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | C peptide [Moles/volume] in Serum or Plasma --1 hour pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.006.024 | Challenge Tests | C Peptide 5 Mins Pre Dose Glucose | 47593-9 | C peptide^5M pre dose glucose | SCnc | Pt | Ser/Plas | Qn | C peptide [Moles/volume] in Serum or Plasma --5 minutes pre dose glucose | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.006.023 | Challenge Tests | C Peptide 5 Mins Pre Challenge | 57648-8 | C peptide^5M pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | C peptide [Moles/volume] in Serum or Plasma --5 minutes pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.006.034 | Challenge Tests | C Peptide 70 Mins Pre Challenge | 57650-4 | C peptide^70M pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | C peptide [Moles/volume] in Serum or Plasma --70 minutes pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.006.045 | Challenge Tests | C Peptide Baseline | 57376-6 | C peptide^baseline | MCnc | Pt | Ser/Plas | Qn | C peptide [Mass/volume] in Serum or Plasma --baseline | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.006.046 | Challenge Tests | C Peptide Fasting | 13037-7 | C peptide^post CFst | MCnc | Pt | Ser/Plas | Qn | C peptide [Mass/volume] in Serum or Plasma --fasting | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.006.047 | Challenge Tests | C Peptide Fasting | 42180-0 | C peptide^post CFst | SCnc | Pt | Ser/Plas | Qn | C peptide [Moles/volume] in Serum or Plasma --fasting | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.006.051 | Challenge Tests | C Peptide Pre Dose Glucagon | 47594-7 | C peptide^pre dose glucagon | SCnc | Pt | Ser/Plas | Qn | C peptide [Moles/volume] in Serum or Plasma --pre dose glucagon | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.006.052 | Challenge Tests | C Peptide Pre Dose Glucose | 58522-4 | C peptide^pre dose glucose | MCnc | Pt | Ser/Plas | Qn | C peptide [Mass/volume] in Serum or Plasma --pre dose glucose | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.006.053 | Challenge Tests | C Peptide Pre Dose Glucose | 47595-4 | C peptide^pre dose glucose | SCnc | Pt | Ser/Plas | Qn | C peptide [Moles/volume] in Serum or Plasma --pre dose glucose | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.185 | Challenge Tests | Creatinine 1.5 Hours Pre Dose | 39956-8 | Creatinine^1.5H pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma --1.5 hours pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.186 | Challenge Tests | Creatinine 1.5 Hours Pre Dose | 40113-3 | Creatinine^1.5H pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | Creatinine [Moles/volume] in Serum or Plasma --1.5 hours pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.200 | Challenge Tests | Creatinine 1 Hour Pre Dose | 39957-6 | Creatinine^1H pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma --1 hour pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.201 | Challenge Tests | Creatinine 1 Hour Pre Dose | 40114-1 | Creatinine^1H pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | Creatinine [Moles/volume] in Serum or Plasma --1 hour pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.216 | Challenge Tests | Creatinine 30 Mins Pre Dose | 39959-2 | Creatinine^30M pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.217 | Challenge Tests | Creatinine 30 Mins Pre Dose | 40116-6 | Creatinine^30M pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | Creatinine [Moles/volume] in Serum or Plasma --30 minutes pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.223 | Challenge Tests | Creatinine 45 Mins Pre Dose | 39958-4 | Creatinine^45M pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma --45 minutes pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.224 | Challenge Tests | Creatinine 45 Mins Pre Dose | 40115-8 | Creatinine^45M pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | Creatinine [Moles/volume] in Serum or Plasma --45 minutes pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.243 | Challenge Tests | Creatinine Baseline | 40248-7 | Creatinine^baseline | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma --baseline | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.244 | Challenge Tests | Creatinine Baseline | 40264-4 | Creatinine^baseline | SCnc | Pt | Ser/Plas | Qn | Creatinine [Moles/volume] in Serum or Plasma --baseline | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.248 | Challenge Tests | Creatinine Pre Dose | 39955-0 | Creatinine^pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma --pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.249 | Challenge Tests | Creatinine Pre Dose | 40112-5 | Creatinine^pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | Creatinine [Moles/volume] in Serum or Plasma --pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.000.436 | Challenge Tests | Glucose Tolerance Interpretation Narrative | 50667-5 | Glucose tolerance | Imp | Pt | Ser/Plas | Nar | Glucose tolerance [Interpretation] in Serum or Plasma Narrative | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.437 | Challenge Tests | Glucose Tolerance Interpretation | 21004-7 | Glucose tolerance | Imp | Pt | Ser/Plas | Nom | Glucose tolerance [Interpretation] in Serum or Plasma | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.438 | Challenge Tests | Glucose Tolerance Interpretation Post 100 g Glucose | 49689-3 | Glucose tolerance^post 100 g glucose PO | Imp | Pt | Ser/Plas | Nar | Glucose tolerance [Interpretation] in Serum or Plasma Narrative--post 100 g glucose PO | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.439 | Challenge Tests | Glucose Tolerance Interpretation Post 75 g Glucose | 49688-5 | Glucose tolerance^post 75 g glucose PO | Imp | Pt | Ser/Plas | Nar | Glucose tolerance [Interpretation] in Serum or Plasma Narrative--post 75 g glucose PO | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.495 | Challenge Tests | Glucose 10 AM Specimen | 16165-3 | Glucose^10 AM specimen | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --10 AM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.496 | Challenge Tests | Glucose 10 PM Specimen | 48991-4 | Glucose^10 PM specimen | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --10 PM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.514 | Challenge Tests | Glucose 10 Mins Pre Dose Glucagon | 54248-0 | Glucose^10M pre dose glucagon | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --10 minutes pre dose glucagon | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.512 | Challenge Tests | Glucose 10 Mins Pre Challenge | 12651-6 | Glucose^10M pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --10 minutes pre XXX challenge | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.513 | Challenge Tests | Glucose 10 Mins Pre Challenge | 40151-3 | Glucose^10M pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --10 minutes pre XXX challenge | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.518 | Challenge Tests | Glucose 11 AM Specimen | 16166-1 | Glucose^11 AM specimen | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --11 AM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.519 | Challenge Tests | Glucose 11 PM Specimen | 59812-8 | Glucose^11 AM specimen | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --11 AM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.527 | Challenge Tests | Glucose 12 AM Specimen | 48992-2 | Glucose^12 AM specimen | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --12 AM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.528 | Challenge Tests | Glucose 12 AM Specimen | 45052-8 | Glucose^12 AM specimen | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --12 AM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.529 | Challenge Tests | Glucose 12 PM Specimen | 48988-0 | Glucose^12 PM specimen | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --12 PM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.530 | Challenge Tests | Glucose 12 PM Specimen | 45054-4 | Glucose^12 PM specimen | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --12 PM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.544 | Challenge Tests | Glucose 13 Mins Pre Challenge | 40261-0 | Glucose^13M pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --13 minutes pre XXX challenge | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.545 | Challenge Tests | Glucose 13 Mins Pre Challenge | 40195-0 | Glucose^13M pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --13 minutes pre XXX challenge | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.570 | Challenge Tests | Glucose 15 Mins Pre Dose Betaxolol | 53481-8 | Glucose^15M pre dose betaxolol | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose betaxolol | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.571 | Challenge Tests | Glucose 15 Mins Pre Dose Glucagon | 54250-6 | Glucose^15M pre dose glucagon | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose glucagon | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.572 | Challenge Tests | Glucose 15 Mins Pre Dose Glucose | 48109-3 | Glucose^15M pre dose glucose | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose glucose | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.573 | Challenge Tests | Glucose 15 Mins Pre Dose Insulin IV | 54261-3 | Glucose^15M pre dose insulin IV | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose insulin IV | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.574 | Challenge Tests | Glucose 15 Mins Pre Dose Ornithine Alpha-ketoglutarate | 54272-0 | Glucose^15M pre dose ornithine alpha-ketoglutarate | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose ornithine alpha-ketoglutarate | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.568 | Challenge Tests | Glucose 15 Mins Pre Challenge | 39999-8 | Glucose^15M pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --15 minutes pre XXX challenge | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.569 | Challenge Tests | Glucose 15 Mins Pre Challenge | 40150-5 | Glucose^15M pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --15 minutes pre XXX challenge | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.596 | Challenge Tests | Glucose 1 Hour Post 100g Glucose | 1501-6 | Glucose^1H post 100 g glucose PO | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --1 hour post 100 g glucose PO | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.597 | Challenge Tests | Glucose 1 Hour Post 100g Glucose | 14753-8 | Glucose^1H post 100 g glucose PO | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --1 hour post 100 g glucose PO | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.598 | Challenge Tests | Glucose 1 Hour Post 50g Glucose | 1504-0 | Glucose^1H post 50 g glucose PO | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g glucose PO | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.599 | Challenge Tests | Glucose 1 Hour Post 50g Glucose | 14754-6 | Glucose^1H post 50 g glucose PO | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g glucose PO | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.603 | Challenge Tests | Glucose 1 Hour Post 75g Glucose | 1507-3 | Glucose^1H post 75 g glucose PO | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.604 | Challenge Tests | Glucose 1 Hour Post 75g Glucose | 51597-3 | Glucose^1H post 75 g glucose PO | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --1 hour post 75 g glucose PO | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.612 | Challenge Tests | Glucose 1 Hour Post Dose Glucose Interp | 19104-9 | Glucose^1H post dose glucose | Imp | Pt | Ser/Plas | Nom | Glucose [Interpretation] in Serum or Plasma--1 hour post dose glucose | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.613 | Challenge Tests | Glucose 1 Hour Post Dose Glucose | 20438-8 | Glucose^1H post dose glucose | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose glucose | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.614 | Challenge Tests | Glucose 1 Hour Post Dose Glucose | 14756-1 | Glucose^1H post dose glucose | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.621 | Challenge Tests | Glucose 1 Hour Post Meal (Postprandial) | 10449-7 | Glucose^1H post meal | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --1 hour post meal | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.622 | Challenge Tests | Glucose 1 Hour Post Meal (Postprandial) | 40287-5 | Glucose^1H post meal | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --1 hour post meal | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.605 | Challenge Tests | Glucose 1 Hour Post Challenge | 12646-6 | Glucose^1H post XXX challenge | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.606 | Challenge Tests | Glucose 1 Hour Post Challenge | 25665-1 | Glucose^1H post XXX challenge | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --1 hour post XXX challenge | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.607 | Challenge Tests | Glucose 1 Hour Post Challenge | 59792-2 | Glucose^1H post XXX challenge | SCncDiff | Pt | Ser/Plas | Qn | Glucose [Molar concentration difference] in Serum or Plasma --1 hour post XXX challenge | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.626 | Challenge Tests | Glucose 1st Specimen Post Challenge | 12615-1 | Glucose^1st specimen post XXX challenge | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.627 | Challenge Tests | Glucose 1st Specimen Post Challenge | 54392-6 | Glucose^1st specimen post XXX challenge | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.629 | Challenge Tests | Glucose 2 PM Specimen | 16167-9 | Glucose^2 PM specimen | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --2 PM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.661 | Challenge Tests | Glucose 20 Mins Pre Challenge | 48983-1 | Glucose^20M pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --20 minutes pre XXX challenge | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.662 | Challenge Tests | Glucose 20 Mins Pre Challenge | 40194-3 | Glucose^20M pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --20 minutes pre XXX challenge | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.688 | Challenge Tests | Deprecated Glucose 2 Hours Post 100 g Glucose | 1515-6 | Glucose^2H post 100 g glucose PO | MCnc | Pt | Ser | Qn | Deprecated Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO | DEPRECATED | PCM Team Decision | Active | 102,00 | ||||||||||||
1.000.689 | Challenge Tests | Glucose 2 Hours Post 100g Glucose | 1514-9 | Glucose^2H post 100 g glucose PO | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.690 | Challenge Tests | Glucose 2 Hours Post 100g Glucose | 14757-9 | Glucose^2H post 100 g glucose PO | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --2 hours post 100 g glucose PO | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.691 | Challenge Tests | Glucose 2 Hours Post 50g Glucose | 41024-1 | Glucose^2H post 50 g glucose PO | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --2 hours post 50 g glucose PO | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.694 | Challenge Tests | Deprecated Glucose 2 Hours Post 75g Glucose | 1519-8 | Glucose^2H post 75 g glucose PO | MCnc | Pt | Ser | Qn | Deprecated Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO | DEPRECATED | PCM Team Decision | Active | 102,00 | ||||||||||||
1.000.695 | Challenge Tests | Glucose 2 Hours Post 75g Glucose | 1518-0 | Glucose^2H post 75 g glucose PO | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.696 | Challenge Tests | Glucose 2 Hours Post 75g Glucose | 14995-5 | Glucose^2H post 75 g glucose PO | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.455 | Challenge Tests | Glucose Blood 2 Hours Post Dose Glucose | 49134-0 | Glucose^2H post dose glucose | MCnc | Pt | Bld | Qn | Glucose [Mass/volume] in Blood --2 hours post dose glucose | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.703 | Challenge Tests | Glucose 2 Hours Post Dose Glucose | 20436-2 | Glucose^2H post dose glucose | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --2 hours post dose glucose | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.704 | Challenge Tests | Glucose 2 Hours Post Dose Glucose | 14759-5 | Glucose^2H post dose glucose | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.456 | Challenge Tests | Glucose Blood 2 Hours Post Meal (Postprandial) | 6689-4 | Glucose^2H post meal | MCnc | Pt | Bld | Qn | Glucose [Mass/volume] in Blood --2 hours post meal | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.457 | Challenge Tests | Glucose Capillary 2 Hours Post Meal (Postprandial) | 14760-3 | Glucose^2H post meal | SCnc | Pt | BldC | Qn | Glucose [Moles/volume] in Capillary blood --2 hours post meal | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.710 | Challenge Tests | Glucose 2 Hours Post Meal (Postprandial) | 1521-4 | Glucose^2H post meal | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --2 hours post meal | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.711 | Challenge Tests | Glucose 2 Hours Post Meal (Postprandial) | 14761-1 | Glucose^2H post meal | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --2 hours post meal | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.712 | Challenge Tests | Glucose Serum, Plasma, or Blood 2 Hours Post Meal (Postprandial) | 77677-3 | Glucose^2H post meal | SCnc | Pt | Ser/Plas/Bld | Qn | Glucose [Moles/volume] in Serum, Plasma or Blood --2 hours post meal | ACTIVE | Use only for a specific International laboratory system. US use discouraged. | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.697 | Challenge Tests | Glucose 2 Hours Post Challenge | 12610-2 | Glucose^2H post XXX challenge | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --2 hours post XXX challenge | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.698 | Challenge Tests | Glucose 2 Hours Post Challenge | 25668-5 | Glucose^2H post XXX challenge | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --2 hours post XXX challenge | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.699 | Challenge Tests | Glucose 2 Hours Post Challenge | 59794-8 | Glucose^2H post XXX challenge | SCncDiff | Pt | Ser/Plas | Qn | Glucose [Molar concentration difference] in Serum or Plasma --2 hours post XXX challenge | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.717 | Challenge Tests | Glucose 2nd Specimen Post Challenge | 12616-9 | Glucose^2nd specimen post XXX challenge | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.718 | Challenge Tests | Glucose 2nd Specimen Post Challenge | 54396-7 | Glucose^2nd specimen post XXX challenge | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.720 | Challenge Tests | Glucose 3 AM Specimen | 48993-0 | Glucose^3 AM specimen | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --3 AM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.721 | Challenge Tests | Glucose 3 PM Specimen | 16168-7 | Glucose^3 PM specimen | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --3 PM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.722 | Challenge Tests | Glucose 3 PM Specimen | 59815-1 | Glucose^3 PM specimen | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --3 PM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.761 | Challenge Tests | Glucose 30 Mins Pre Dose Betaxolol | 53484-2 | Glucose^30M pre dose betaxolol | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --30 minutes pre dose betaxolol | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.759 | Challenge Tests | Glucose 30 Mins Pre Challenge | 39998-0 | Glucose^30M pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.760 | Challenge Tests | Glucose 30 Mins Pre Challenge | 40149-7 | Glucose^30M pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --30 minutes pre XXX challenge | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.768 | Challenge Tests | Glucose 3 Hours Post 100g Glucose | 1530-5 | Glucose^3H post 100 g glucose PO | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --3 hours post 100 g glucose PO | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.769 | Challenge Tests | Glucose 3 Hours Post 100g Glucose | 14764-5 | Glucose^3H post 100 g glucose PO | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --3 hours post 100 g glucose PO | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.771 | Challenge Tests | Glucose 3 Hours Post 75g Glucose | 1533-9 | Glucose^3H post 75 g glucose PO | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.772 | Challenge Tests | Glucose 3 Hours Post 75g Glucose | 32320-4 | Glucose^3H post 75 g glucose PO | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --3 hours post 75 g glucose PO | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.778 | Challenge Tests | Glucose 3 Hours Post Dose Glucose Interpretation | 19105-6 | Glucose^3H post dose glucose | Imp | Pt | Ser/Plas | Nom | Glucose [Interpretation] in Serum or Plasma--3 hours post dose glucose | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.779 | Challenge Tests | Glucose 3 Hours Post Dose Glucose | 20437-0 | Glucose^3H post dose glucose | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --3 hours post dose glucose | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.780 | Challenge Tests | Glucose 3 Hours Post Dose Glucose | 14765-2 | Glucose^3H post dose glucose | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --3 hours post dose glucose | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.773 | Challenge Tests | Glucose 3 Hours Post Challenge | 18342-6 | Glucose^3H post XXX challenge | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --3 hours post XXX challenge | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.774 | Challenge Tests | Glucose 3 Hours Post Challenge | 40162-0 | Glucose^3H post XXX challenge | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --3 hours post XXX challenge | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.775 | Challenge Tests | Glucose 3 Hours Post Challenge | 59795-5 | Glucose^3H post XXX challenge | SCncDiff | Pt | Ser/Plas | Qn | Glucose [Molar concentration difference] in Serum or Plasma --3 hours post XXX challenge | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.785 | Challenge Tests | Glucose 3 Hours Pre Dose Insulin IV | 54262-1 | Glucose^3H pre dose insulin IV | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --3 hours pre dose insulin IV | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.789 | Challenge Tests | Glucose 3 Mins Pre Challenge | 40262-8 | Glucose^3M pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --3 minutes pre XXX challenge | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.790 | Challenge Tests | Glucose 3 Mins Pre Challenge | 40197-6 | Glucose^3M pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --3 minutes pre XXX challenge | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.792 | Challenge Tests | Glucose 3rd Specimen Post Challenge | 12617-7 | Glucose^3rd specimen post XXX challenge | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.793 | Challenge Tests | Glucose 3rd Specimen Post Challenge | 54397-5 | Glucose^3rd specimen post XXX challenge | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.795 | Challenge Tests | Glucose 4 AM Specimen | 53474-3 | Glucose^4 AM specimen | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --4 AM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.796 | Challenge Tests | Glucose 4 PM Specimen | 16169-5 | Glucose^4 PM specimen | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --4 PM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.797 | Challenge Tests | Glucose 4 PM Specimen | 45055-1 | Glucose^4 PM specimen | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --4 PM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.841 | Challenge Tests | Glucose 4th Specimen Post Challenge | 12618-5 | Glucose^4th specimen post XXX challenge | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.842 | Challenge Tests | Glucose 4th Specimen Post Challenge | 54398-3 | Glucose^4th specimen post XXX challenge | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.844 | Challenge Tests | Glucose 5 PM Specimen | 16170-3 | Glucose^5 PM specimen | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --5 PM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.869 | Challenge Tests | Glucose 5 Mins Pre Dose Glucagon | 54254-8 | Glucose^5M pre dose glucagon | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --5 minutes pre dose glucagon | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.867 | Challenge Tests | Glucose 5 Mins Pre Challenge | 40000-2 | Glucose^5M pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --5 minutes pre XXX challenge | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.868 | Challenge Tests | Glucose 5 Mins Pre Challenge | 40152-1 | Glucose^5M pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --5 minutes pre XXX challenge | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.874 | Challenge Tests | Glucose 6 AM Specimen | 48994-8 | Glucose^6 AM specimen | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --6 AM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.875 | Challenge Tests | Glucose 6 PM Specimen | 48989-8 | Glucose^6 PM specimen | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --6 PM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.892 | Challenge Tests | Glucose 7 AM Specimen | 59814-4 | Glucose^7 AM specimen | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --7 AM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.907 | Challenge Tests | Glucose 8 AM Specimen | 48986-4 | Glucose^8 AM specimen | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --8 AM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.908 | Challenge Tests | Glucose 8 AM Specimen | 45053-6 | Glucose^8 AM specimen | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --8 AM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.909 | Challenge Tests | Glucose 8 PM Specimen | 48990-6 | Glucose^8 PM specimen | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --8 PM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.910 | Challenge Tests | Glucose 8 PM Specimen | 45056-9 | Glucose^8 PM specimen | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --8 PM specimen | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.919 | Challenge Tests | Glucose 8 Mins Pre Challenge | 40196-8 | Glucose^8M pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --8 minutes pre XXX challenge | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.459 | Challenge Tests | Glucose Capillary Baseline | 40858-3 | Glucose^baseline | MCnc | Pt | BldC | Qn | Glucose [Mass/volume] in Capillary blood --baseline | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.933 | Challenge Tests | Glucose Baseline | 1547-9 | Glucose^baseline | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --baseline | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.934 | Challenge Tests | Glucose Baseline | 14768-6 | Glucose^baseline | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --baseline | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.935 | Challenge Tests | Glucose 10 Hours Fasting | 10450-5 | Glucose^post 10H CFst | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --10 hours fasting | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.936 | Challenge Tests | Glucose 12 Hours Fasting | 1554-5 | Glucose^post 12H CFst | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --12 hours fasting | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.937 | Challenge Tests | Glucose Post 50 g Glucose | 20441-2 | Glucose^post 50 g glucose | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --post 50 g glucose | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.938 | Challenge Tests | Glucose 8 Hours Fasting | 17865-7 | Glucose^post 8H CFst | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --8 hours fasting | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.945 | Challenge Tests | Glucose Post Dose Glucose Interpretation | 18296-4 | Glucose^post dose glucose | Imp | Pt | Ser/Plas | Nom | Glucose [Interpretation] in Serum or Plasma--post dose glucose | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.465 | Challenge Tests | Glucose Blood Post Meal (Postprandial) | 87422-2 | Glucose^post meal | MCnc | Pt | Bld | Qn | Glucose [Mass/volume] in Blood --post meal | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.946 | Challenge Tests | Glucose Post Meal (Postprandial) | 16915-1 | Glucose^post meal | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --post meal | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.947 | Challenge Tests | Glucose Post Meal (Postprandial) | 53094-9 | Glucose^post meal | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --post meal | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.942 | Challenge Tests | Glucose Post Challenge | 16914-4 | Glucose^post XXX challenge | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --post XXX challenge | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.943 | Challenge Tests | Glucose Post Challenge | 53093-1 | Glucose^post XXX challenge | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --post XXX challenge | X | ACTIVE | PCM Team Decision | Active | 102,00 | |||||||||||
1.000.948 | Challenge Tests | Glucose Pre 0.5 g/kg Glucose IV | 1548-7 | Glucose^pre 0.5 g/kg glucose IV | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --pre 0.5 g/kg glucose IV | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.949 | Challenge Tests | Glucose Pre 100 g Glucose | 1549-5 | Glucose^pre 100 g glucose PO | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --pre 100 g glucose PO | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.950 | Challenge Tests | Glucose Pre 100 g Glucose | 70208-4 | Glucose^pre 100 g glucose PO | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --pre 100 g glucose PO | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.951 | Challenge Tests | Glucose Pre 12 Hour Fast | 1550-3 | Glucose^pre 12H CFst | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --pre 12 hour fast | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.952 | Challenge Tests | Glucose Pre 12 Hour Fast | 14769-4 | Glucose^pre 12H CFst | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --pre 12 hour fast | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.953 | Challenge Tests | Glucose Pre 50 g Glucose | 25680-0 | Glucose^pre 50 g glucose PO | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --pre 50 g glucose PO | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.954 | Challenge Tests | Glucose Pre 50 g Lactose | 1551-1 | Glucose^pre 50 g lactose PO | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --pre 50 g lactose PO | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.955 | Challenge Tests | Glucose Pre 75 g Glucose | 1552-9 | Glucose^pre 75 g glucose PO | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --pre 75 g glucose PO | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.956 | Challenge Tests | Glucose Pre 75 g Glucose | 14996-3 | Glucose^pre 75 g glucose PO | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --pre 75 g glucose PO | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.959 | Challenge Tests | Glucose Pre Dose Betaxolol | 53475-0 | Glucose^pre dose betaxolol | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --pre dose betaxolol | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.960 | Challenge Tests | Glucose Pre Dose Fructose | 48606-8 | Glucose^pre dose fructose PO | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --pre dose fructose PO | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.961 | Challenge Tests | Glucose Pre Dose Glucagon | 54400-7 | Glucose^pre dose glucagon | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --pre dose glucagon | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.962 | Challenge Tests | Glucose Pre Dose Glucose | 47622-6 | Glucose^pre dose glucose | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --pre dose glucose | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.963 | Challenge Tests | Glucose Pre Dose Insulin IV | 1553-7 | Glucose^pre dose insulin IV | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --pre dose insulin IV | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.964 | Challenge Tests | Glucose Pre Dose Insulin IV | 54257-1 | Glucose^pre dose insulin IV | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --pre dose insulin IV | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.965 | Challenge Tests | Glucose Pre Dose Lactose | 12638-3 | Glucose^pre dose lactose PO | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --pre dose lactose PO | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.966 | Challenge Tests | Glucose Pre Dose Lactose | 59157-8 | Glucose^pre dose lactose PO | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --pre dose lactose PO | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.967 | Challenge Tests | Glucose Pre Dose Ornithine Alpha-ketoglutarate | 54268-8 | Glucose^pre dose ornithine alpha-ketoglutarate | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --pre dose ornithine alpha-ketoglutarate | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.968 | Challenge Tests | Glucose Pre Dose Triple Bolus | 40318-8 | Glucose^pre dose triple bolus | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --pre dose triple bolus | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.957 | Challenge Tests | Glucose Pre Challenge | 39997-2 | Glucose^pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --pre XXX challenge | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.958 | Challenge Tests | Glucose Pre Challenge | 40148-9 | Glucose^pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --pre XXX challenge | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.466 | Challenge Tests | Deprecated Glucose Blood Pre Meal | 87421-4 | Glucose^pre-meal | MCnc | - | Bld | Qn | Deprecated Glucose [Mass/volume] in Blood --pre-meal | DEPRECATED | 83% | Active | 102,00 | ||||||||||||
1.000.467 | Challenge Tests | Glucose Blood Pre Meal | 88365-2 | Glucose^pre-meal | MCnc | Pt | Bld | Qn | Glucose [Mass/volume] in Blood --pre-meal | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.975 | Challenge Tests | Glucose Pre Meal | 53049-3 | Glucose^pre-meal | MCnc | Pt | Ser/Plas | Qn | Glucose [Mass/volume] in Serum or Plasma --pre-meal | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.000.976 | Challenge Tests | Glucose Pre Meal | 40193-5 | Glucose^pre-meal | SCnc | Pt | Ser/Plas | Qn | Glucose [Moles/volume] in Serum or Plasma --pre-meal | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
1.003.346 | Challenge Tests | Thyrotropin (TSH) 15 Mins Pre Challenge | 58834-3 | Thyrotropin^15M pre XXX challenge | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --15 minutes pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.003.363 | Challenge Tests | Thyrotropin (TSH) 20 Mins Pre Challenge (Discouraged) | 58833-5 | Thyrotropin^20M pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Thyrotropin [Mass/volume] in Serum or Plasma --20 minutes pre XXX challenge | DISCOURAGED | 100% | Active | 102,00 | ||||||||||||
1.003.377 | Challenge Tests | Thyrotropin (TSH) 30 Mins Pre Challenge | 12940-3 | Thyrotropin^30M pre XXX challenge | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --30 minutes pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
1.003.400 | Challenge Tests | Thyrotropin (TSH) Pre Challenge | 55362-8 | Thyrotropin^pre XXX challenge | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
Associated Problem ID | Associated Problem Name | Data Domain | Coding System | Coding System Version | Lab Primary Key | Clinical Category | Result Name | LOINC Code | LOINC Component | LOINC Property | LOINC Time | LOINC System | LOINC Scale | LOINC Method | LOINC Long Name | Common US Use | Common Intl Use | Also Consider | LOINC Status | External Comments | PCM Status | Release Change Comments | PCM Version First Released | PCM Version Last Updated |
Medications
Associated Problem ID | Associated Problem Name | Data Domain | Coding System | Coding System Version | Med Primary Key | Category | RxNorm Subclass | Medication | RxNorm Code | Term Type | Exclude Routes | NCI Code | International Use | External Comments | PCM Status | % Consensus Agreement | Release Change Comments | PCM Version First Released | PCM Version Last Updated |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1.007 | Diabetes Mellitus | Medications | RxNorm | 01/12/2019 | 1.001.076 | Anti-Diabetic Agents | Alpha Glucosidase Inhibitors | acarbose | 16681 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | ||||
1.001.083 | Anti-Diabetic Agents | Alpha Glucosidase Inhibitors | miglitol | 30009 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.085 | Anti-Diabetic Agents | Biguanides | metformin | 6809 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.086 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | alogliptin / metformin | 1368384 | MIN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.089 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | alogliptin / pioglitazone | 1368402 | MIN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.090 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | canagliflozin / metformin | 1545149 | MIN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.101 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | dapagliflozin / metformin | 1486436 | MIN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.010.938 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | dapagliflozin / metformin / saxagliptin | 2117292 | MIN | Active | 100% | Field Updated (% Consensus Agreement) | 102,00 | 1.02.2 | |||||||||
1.001.107 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | dapagliflozin / saxagliptin | 1727500 | MIN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.109 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | empagliflozin / linagliptin | 1598392 | MIN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.155 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | empagliflozin / linagliptin / metformin | 2281864 | MIN | Active | 100% | Field Updated (Medication) | 102,00 | 1.02.2 | |||||||||
1.001.120 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | empagliflozin / metformin | 1664314 | MIN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.153 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | ertugliflozin / metformin | 1992684 | MIN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.154 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | ertugliflozin / sitagliptin | 1992825 | MIN | Active | 100% | Field Updated (% Consensus Agreement) | 102,00 | 1.02.2 | |||||||||
1.001.121 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | glimepiride / pioglitazone | 647235 | MIN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.124 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | glimepiride / rosiglitazone | 606253 | MIN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.152 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | glyburide / metformin | 285129 | MIN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.125 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | linagliptin / metformin | 1243019 | MIN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.129 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | metformin / pioglitazone | 607999 | MIN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.133 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | metformin / repaglinide | 802646 | MIN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.134 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | metformin / rosiglitazone | 614348 | MIN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.137 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | metformin / saxagliptin | 1043562 | MIN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.138 | Anti-Diabetic Agents | Combinations of Oral Blood Glucose Lowering Agents | metformin / sitagliptin | 729717 | MIN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.139 | Anti-Diabetic Agents | Dipeptidyl Peptidase-4 (DPP-4) Inhibitors | alogliptin | 1368001 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.140 | Anti-Diabetic Agents | Dipeptidyl Peptidase-4 (DPP-4) Inhibitors | linagliptin | 1100699 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.142 | Anti-Diabetic Agents | Dipeptidyl Peptidase-4 (DPP-4) Inhibitors | saxagliptin | 857974 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.143 | Anti-Diabetic Agents | Dipeptidyl Peptidase-4 (DPP-4) Inhibitors | sitagliptin | 593411 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.144 | Anti-Diabetic Agents | Glucagon-Like Peptide-1 (GLP-1) Inhibitors | dulaglutide | 1551291 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.147 | Anti-Diabetic Agents | Glucagon-Like Peptide-1 (GLP-1) Inhibitors | exenatide | 60548 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.256 | Anti-Diabetic Agents | Glucagon-Like Peptide-1 (GLP-1) Inhibitors | liraglutide | 475968 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.298 | Anti-Diabetic Agents | Glucagon-Like Peptide-1 (GLP-1) Inhibitors | lixisenatide | 1440051 | IN | Active | 100% | Field Updated (% Consensus Agreement) | 102,00 | 1.02.2 | |||||||||
1.006.149 | Anti-Diabetic Agents | Glucagon-Like Peptide-1 (GLP-1) Inhibitors | semaglutide | 1991302 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.126 | Anti-Diabetic Agents | Insulin / GLP-1 Inhibitor Combinations | insulin degludec / liraglutide | 1727493 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.006.142 | Anti-Diabetic Agents | Other Blood Glucose Lowering Agents | mifepristone | 6964 | IN | Active | 100% | Field Updated (% Consensus Agreement) | 102,00 | 1.02.2 | |||||||||
1.006.140 | Anti-Diabetic Agents | Other Blood Glucose Lowering Agents | nateglinide | 274332 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.139 | Anti-Diabetic Agents | Other Blood Glucose Lowering Agents | pramLintide | 139953 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.141 | Anti-Diabetic Agents | Other Blood Glucose Lowering Agents | repaglinide | 73044 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.128 | Anti-Diabetic Agents | Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors | canagliflozin | 1373458 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.129 | Anti-Diabetic Agents | Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors | dapagliflozin | 1488564 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.130 | Anti-Diabetic Agents | Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors | empagliflozin | 1545653 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.150 | Anti-Diabetic Agents | Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors | ertugliflozin | 1992672 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.131 | Anti-Diabetic Agents | Sulfonylureas | chlorpropamide | 2404 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.132 | Anti-Diabetic Agents | Sulfonylureas | glimepiride | 25789 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.133 | Anti-Diabetic Agents | Sulfonylureas | glipizide | 4821 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.134 | Anti-Diabetic Agents | Sulfonylureas | glyburide | 4815 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.135 | Anti-Diabetic Agents | Sulfonylureas | tolazamide | 10633 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.136 | Anti-Diabetic Agents | Sulfonylureas | tolbutamide | 10635 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.017.460 | Anti-Diabetic Agents | Thiazolidinediones | pioglitazone | 33738 | IN | Active | 100% | New Entry (PCM) | 1.022,00 | 1.02.2 | |||||||||
1.006.137 | Anti-Diabetic Agents | Thiazolidinediones | pioglitazone hydrochloride | 259319 | PIN | Inactive | 100% | Entry Inactivated | 102,00 | 1.02.2 | |||||||||
1.017.461 | Anti-Diabetic Agents | Thiazolidinediones | rosiglitazone | 84108 | IN | Active | 100% | New Entry (PCM) | 1.022,00 | 1.02.2 | |||||||||
1.006.138 | Anti-Diabetic Agents | Thiazolidinediones | rosiglitazone maleate | 253198 | PIN | Inactive | 100% | Entry Inactivated | 102,00 | 1.02.2 | |||||||||
1.006.127 | Anti-Diabetic Agents, Combinations | Insulin / GLP-1 Inhibitor Combinations | Insulin glargine / lixisenatide | 1858994 | MIN | Active | 100% | Fields Updated (Category,RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.017.434 | Anti-Hyperlipidemics | Angiopoietin-like 3 Protein (ANGPTL3) Inhibitors | evinacumab | 2478335 | IN | Active | PCM Team Decision | New Entry (PCM) | 1.022,00 | 1.02.2 | |||||||||
1.017.435 | Anti-Hyperlipidemics | Angiopoietin-like 3 Protein (ANGPTL3) Inhibitors | evinacumab-dgnb | 2478646 | PIN | Inactive | PCM Team Decision | New Entry (PCM) | 1.022,00 | 1.02.2 | |||||||||
1.001.096 | Anti-Hyperlipidemics | Antilipemic Agents | omega-3 acid ethyl esters (USP) | 484348 | IN | Active | 83% | 102,00 | 1.02 | ||||||||||
1.001.095 | Anti-Hyperlipidemics | Antilipemic Agents and Vitamin D and Analogues | cholecalciferol / omega-3 acid ethyl esters (USP) | 1041795 | MIN | Active | 83% | 102,00 | 1.02 | ||||||||||
1.001.084 | Anti-Hyperlipidemics | Bile Acid Sequestrants | cholestyramine resin | 2447 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.431 | Anti-Hyperlipidemics | Bile Acid Sequestrants | colesevelam | 141626 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.432 | Anti-Hyperlipidemics | Bile Acid Sequestrants | colestipol | 2685 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.093 | Anti-Hyperlipidemics | Combinations of Various Lipid Modifying Agents | atorvastatin / ezetimibe | 1422085 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.094 | Anti-Hyperlipidemics | Combinations of Various Lipid Modifying Agents | ezetimibe / simvastatin | 484211 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.078 | Anti-Hyperlipidemics | Combinations of Various Lipid Modifying Agents | lovastatin / niacin | 352387 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.079 | Anti-Hyperlipidemics | Combinations of Various Lipid Modifying Agents | niacin / simvastatin | 803516 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.087 | Anti-Hyperlipidemics | Fibrates | choline fenofibrate | 1433887 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.088 | Anti-Hyperlipidemics | Fibrates | fenofibrate | 8703 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.147 | Anti-Hyperlipidemics | Fibrates | fenofibrate micronized | 221100 | PIN | Inactive | 100% | Entry Inactivated | 102,00 | 1.02.2 | |||||||||
1.006.148 | Anti-Hyperlipidemics | Fibrates | fenofibric acid | 24852 | PIN | Inactive | 100% | Entry Inactivated | 102,00 | 1.02.2 | |||||||||
1.001.091 | Anti-Hyperlipidemics | Fibrates | gemfibrozil | 4719 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.433 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | atorvastatin | 83367 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.434 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | fluvastatin | 41127 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.073 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | lovastatin | 6472 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.435 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | pitavastatin | 861634 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.436 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | pravastatin | 42463 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.437 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | rosuvastatin | 301542 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.077 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | simvastatin | 36567 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.317 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors in Combinations with Anti-Hypertensives | amlodipine / atorvastatin | 404773 | MIN | Active | PCM Team Decision | New Entry (PCM) | 1.022,00 | 1.02.2 | |||||||||
1.001.092 | Anti-Hyperlipidemics | Nicotinic Acid and Derivatives | niacin | 7393 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.082 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | ezetimibe | 341248 | IN | Active | 83% | 102,00 | 1.02 | ||||||||||
1.001.438 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | icosapent ethyl | 1304974 | IN | Active | 83% | 102,00 | 1.02 | ||||||||||
1.001.439 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | lomitapide | 1364479 | IN | Active | 83% | 102,00 | 1.02 | ||||||||||
1.001.440 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | mipomersen | 1367839 | IN | Active | 67% | 102,00 | 1.02 | ||||||||||
1.001.442 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | probucol | 8699 | IN | X | Active | 67% | Field Updated (International Use) | 102,00 | 1.02.2 | ||||||||
1.001.080 | Anti-Hyperlipidemics | Proprotein Convertase Subtilisin / Kexin Type 9 (PCSK9) Inhibitors | alirocumab | 1659152 | IN | Active | 83% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.081 | Anti-Hyperlipidemics | Proprotein Convertase Subtilisin / Kexin Type 9 (PCSK9) Inhibitors | evolocumab | 1665684 | IN | Active | 83% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.003.208 | Anti-Hypertensives | ACE Inhibitors, Plain | benazepril | 18867 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.102 | Anti-Hypertensives | ACE Inhibitors, Plain | captopril | 1998 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.004.449 | Anti-Hypertensives | ACE Inhibitors, Plain | enalapril | 3827 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.104 | Anti-Hypertensives | ACE Inhibitors, Plain | enalaprilat | 3829 | IN | Active | 100% | Field Updated (% Consensus Agreement) | 102,00 | 1.02.2 | |||||||||
1.004.450 | Anti-Hypertensives | ACE Inhibitors, Plain | fosinopril | 50166 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.106 | Anti-Hypertensives | ACE Inhibitors, Plain | lisinopril | 29046 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.003.209 | Anti-Hypertensives | ACE Inhibitors, Plain | moexipril | 30131 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.004.451 | Anti-Hypertensives | ACE Inhibitors, Plain | perindopril | 54552 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.003.210 | Anti-Hypertensives | ACE Inhibitors, Plain | quinapril | 35208 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.110 | Anti-Hypertensives | ACE Inhibitors, Plain | ramipril | 35296 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.001.111 | Anti-Hypertensives | ACE Inhibitors, Plain | trandolapril | 38454 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.004.444 | Anti-Hypertensives | Angiotensin II Receptor Blockers (ARBs), Plain | azilsartan | 1091643 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.004.445 | Anti-Hypertensives | Angiotensin II Receptor Blockers (ARBs), Plain | candesartan | 214354 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.004.446 | Anti-Hypertensives | Angiotensin II Receptor Blockers (ARBs), Plain | eprosartan | 83515 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.115 | Anti-Hypertensives | Angiotensin II Receptor Blockers (ARBs), Plain | irbesartan | 83818 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.004.447 | Anti-Hypertensives | Angiotensin II Receptor Blockers (ARBs), Plain | losartan | 52175 | IN | Active | 100% | Fields Updated (RxNorm Subclass,% Consensus Agreement) | 102,00 | 1.02.2 | |||||||||
1.004.448 | Anti-Hypertensives | Angiotensin II Receptor Blockers (ARBs), Plain | olmesartan | 321064 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.118 | Anti-Hypertensives | Angiotensin II Receptor Blockers (ARBs), Plain | telmisartan | 73494 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.119 | Anti-Hypertensives | Angiotensin II Receptor Blockers (ARBs), Plain | valsartan | 69749 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.151 | Anti-Hypertensives | Antihypertensive Combinations | aliskiren / valsartan | 900937 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.152 | Anti-Hypertensives | Antihypertensive Combinations | amlodipine / benazepril | 214223 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.174 | Anti-Hypertensives | Antihypertensive Combinations | amlodipine / hydrochlorothiazide / olmesartan | 1008801 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.175 | Anti-Hypertensives | Antihypertensive Combinations | amlodipine / perindopril | 1033889 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.178 | Anti-Hypertensives | Antihypertensive Combinations | amlodipine / telmisartan | 901212 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.153 | Anti-Hypertensives | Antihypertensive Combinations | amlodipine / valsartan | 729455 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.154 | Anti-Hypertensives | Antihypertensive Combinations | amlodipine/ olmesartan | 1009015 | MIN | Active | 100% | Fields Updated (RxNorm Subclass,Medication) | 102,00 | 1.02.2 | |||||||||
1.001.157 | Anti-Hypertensives | Antihypertensive Combinations | azilsartan / chlorthalidone | 1235143 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.158 | Anti-Hypertensives | Antihypertensive Combinations | benazepril / hydrochlorothiazide | 214287 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.160 | Anti-Hypertensives | Antihypertensive Combinations | candesartan / hydrochlorothiazide | 284628 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.161 | Anti-Hypertensives | Antihypertensive Combinations | captopril / hydrochlorothiazide | 214357 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.155 | Anti-Hypertensives | Antihypertensive Combinations | enalapril / diltiazem | 214507 | MIN | Active | 100% | Fields Updated (RxNorm Subclass,Medication,RxNorm Code) | 102,00 | 1.02.2 | |||||||||
1.001.163 | Anti-Hypertensives | Antihypertensive Combinations | enalapril / hydrochlorothiazide | 214536 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.164 | Anti-Hypertensives | Antihypertensive Combinations | eprosartan / hydrochlorothiazide | 352375 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.165 | Anti-Hypertensives | Antihypertensive Combinations | fosinopril / hydrochlorothiazide | 261415 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.166 | Anti-Hypertensives | Antihypertensive Combinations | hydrochlorothiazide / irbesartan | 214617 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.167 | Anti-Hypertensives | Antihypertensive Combinations | hydrochlorothiazide / lisinopril | 214618 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.168 | Anti-Hypertensives | Antihypertensive Combinations | hydrochlorothiazide / losartan | 214619 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.171 | Anti-Hypertensives | Antihypertensive Combinations | hydrochlorothiazide / moexipril | 214622 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.173 | Anti-Hypertensives | Antihypertensive Combinations | hydrochlorothiazide / olmesartan | 817496 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.177 | Anti-Hypertensives | Antihypertensive Combinations | hydrochlorothiazide / quinapril | 261417 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.179 | Anti-Hypertensives | Antihypertensive Combinations | hydrochlorothiazide / telmisartan | 284636 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.181 | Anti-Hypertensives | Antihypertensive Combinations | hydrochlorothiazide / valsartan | 214626 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.001.180 | Anti-Hypertensives | Antihypertensive Combinations | trandolapril / verapamil | 214866 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.2 | |||||||||
1.006.143 | Anti-Hypoglycemic Agents | Carbohydrates | glucose | 4850 | IN | Active | 67% | 102,00 | 1.02 | ||||||||||
1.017.458 | Anti-Hypoglycemic Agents | Glycogenolytic Hormones | glucagon | 4832 | IN | Active | 83% | New Entry (PCM) | 1.022,00 | 1.02.2 | |||||||||
1.006.145 | Anti-Hypoglycemic Agents | Glycogenolytic Hormones | glucagon (rdna) | 261716 | PIN | Inactive | 83% | Entry Inactivated | 102,00 | 1.02.2 | |||||||||
1.006.144 | Anti-Hypoglycemic Agents | Inhibitors of Pancreatic Insulin Release | diazoxide | 3327 | IN | Active | 83% | 102,00 | 1.02 | ||||||||||
1.006.146 | Anti-Hypoglycemic Agents | Vitamins + Carbohydrates | ascorbic acid / glucose | 821174 | MIN | Active | 67% | 102,00 | 1.02 | ||||||||||
1.006.151 | Ergot Alkaloids | Dopamine Agonists | bromocriptine | 1760 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.016.793 | Insulin Combinations | Insulin Combinations | insulin aspart protamine, human / insulin aspart, human | 1007184 | MIN | Active | 100% | New Entry (PCM) | 1.022,00 | 1.02.2 | |||||||||
1.006.125 | Insulin Combinations | Insulin Combinations | insulin isophane / insulin, regular, human | 1008501 | MIN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.006.124 | Insulin Combinations | Insulin Combinations | Insulin lispro / insulin lispro protamine, human | 816726 | MIN | Active | 100% | 102,00 | 1.02 | ||||||||||
1.011.072 | Insulin Combinations | Insulin Combinations | Insulin protamine aspart / Insulin aspart 70/30 | 977838 | MIN | Inactive | 100% | Entry Inactivated | 102,00 | 1.02.2 | |||||||||
1.001.430 | Insulins | Insulins and Analogues | insulin aspart, human | 51428 | IN | Active | 100% | Field Updated (Category) | 102,00 | 1.02.2 | |||||||||
1.004.452 | Insulins | Insulins and Analogues | insulin degludec | 1670007 | IN | Active | 100% | Field Updated (Category) | 102,00 | 1.02.2 | |||||||||
1.004.453 | Insulins | Insulins and Analogues | insulin detemir | 139825 | IN | Active | 100% | Field Updated (Category) | 102,00 | 1.02.2 | |||||||||
1.006.119 | Insulins | Insulins and Analogues | Insulin glargine | 274783 | IN | Active | 100% | Field Updated (Category) | 102,00 | 1.02.2 | |||||||||
1.006.120 | Insulins | Insulins and Analogues | insulin glulisine, human | 400008 | IN | Active | 100% | Field Updated (Category) | 102,00 | 1.02.2 | |||||||||
1.017.459 | Insulins | Insulins and Analogues | insulin isophane | 1605101 | IN | Active | 100% | New Entry (PCM) | 1.022,00 | 1.02.2 | |||||||||
1.006.122 | Insulins | Insulins and Analogues | insulin isophane, human | 253181 | PIN | Inactive | 100% | Entry Inactivated | 102,00 | 1.02.2 | |||||||||
1.006.121 | Insulins | Insulins and Analogues | Insulin lispro | 86009 | IN | Active | 100% | Field Updated (Category) | 102,00 | 1.02.2 | |||||||||
1.006.123 | Insulins | Insulins and Analogues | insulin, regular, human | 253182 | IN | Active | 100% | Field Updated (Category) | 102,00 | 1.02.2 | |||||||||
Associated Problem ID | Associated Problem Name | Data Domain | Coding System | Coding System Version | Med Primary Key | Category | RxNorm Subclass | Medication | RxNorm Code | Term Type | Exclude Routes | NCI Code | International Use | External Comments | PCM Status | % Consensus Agreement | Release Change Comments | PCM Version First Released | PCM Version Last Updated |
Definition
All Problems on this web site are defined as a set of SNOMED CT codes. To view a term and its descendants, go to the International SNOMED site. Then, if in the United States, see LOCAL EXTENSIONS and select the US Browser. Enter the term number or name.
Problems with the following codes (and their descendants) will trigger the map according to the logic listed.
Associated Problem ID | Associated Problem Name | Data Domain | Coding System | Coding System Version | Row | Include Descendants? | Clinical Name | SNOMED CT Fully Specified Name (FSN) | SNOMED CT | Logic |
---|---|---|---|---|---|---|---|---|---|---|
1.007 | Diabetes Mellitus | Definition | SNOMED CT | 01/07/2019 | 1 | Y | Diabetes mellitus | 73211009 | (1 OR 2 OR 3 OR 4) AND NOT 5 | |
2 | Y | Diabetic monitoring status | 243860001 | |||||||
3 | Y | Diabetic complication | 74627003 | |||||||
4 | Y | H/O diabetes mellitus | 161445009 | |||||||
5 | Y | At risk of disease | 313424005 |
Copyright © 2016-2020. Board of Regents of the University of Wisconsin System. All rights reserved.